Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0022885,
umls-concept:C0039593,
umls-concept:C0077404,
umls-concept:C0184511,
umls-concept:C0205210,
umls-concept:C0205216,
umls-concept:C0439831,
umls-concept:C0597198,
umls-concept:C0750491,
umls-concept:C0936012,
umls-concept:C1522564,
umls-concept:C1883709,
umls-concept:C2603343,
umls-concept:C2718050
|
pubmed:issue |
6
|
pubmed:dateCreated |
1997-11-21
|
pubmed:abstractText |
In a multicentre study, we evaluated the analytical and diagnostic performance of the second version of the TROPT rapid test (TROPT 2, CARDIACT in the US). We tested TROPT 2 on 796 blood samples from 487 patients admitted on suspicion of myocardial infarction between 1 and 72 h after onset of symptoms and determined cTnT ELISA and CK MB mass in the corresponding serum samples. Frequency distributions of the results with TROPT 2 showed a detection limit of 0.18 microgram/l (for 50% positive results) as determined by the quantitative cTnT ELISA method. In a total of 796 samples the sensitivities in the detection of myocardial infarction (WHO criteria) 8-12 h after onset of symptoms were highest for cTnT ELISA (98%), followed by the rapid assay and CK MB mass (92%). A subgroup of 87 patients was primarily classified by the WHO criteria for definite infarction. Based on the maximum values within each patient time-series, diagnostic sensitivities for infarction were 100% for TROPT2, cTnT ELISA and CK MB mass. The corresponding specificities were 90%, 82% and 100%, respectively. After reclassification summarizing all cases of myocardial damage (acute and subacute myocardial infarctions and minor myocardial damage) the sensitivities were 87% (TROPT2), 100% (cTnT ELISA) and 71% (CK MB mass). The specificities of all three markers were 100%. Over 50% of all cases of minor myocardial damage were detected by TROPT 2. The clinical evaluation showed that the diagnostic performance of TROPT 2 is only slightly lower than that of cTnT ELISA.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0036-5513
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
57
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
549-57
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9350075-Angina, Unstable,
pubmed-meshheading:9350075-Creatine Kinase,
pubmed-meshheading:9350075-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:9350075-Humans,
pubmed-meshheading:9350075-Isoenzymes,
pubmed-meshheading:9350075-Kinetics,
pubmed-meshheading:9350075-Microchemistry,
pubmed-meshheading:9350075-Myocardial Infarction,
pubmed-meshheading:9350075-Regression Analysis,
pubmed-meshheading:9350075-Sensitivity and Specificity,
pubmed-meshheading:9350075-Troponin,
pubmed-meshheading:9350075-Troponin T
|
pubmed:year |
1997
|
pubmed:articleTitle |
An improved rapid troponin T test with a decreased detection limit: a multicentre study of the analytical and clinical performance in suspected myocardial damage.
|
pubmed:affiliation |
Department of Clinical Chemistry, Lasarettet, Helsingborg, Sweden.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Multicenter Study
|